2026 Cholesterol Guideline and VESALIUS-CV: What the New Data Say About PCSK9-Pathway Therapy in India
1. Why Cholesterol Guidance Is in the News Again Over the past twelve months, cardiology has produced an unusually dense run of lipid-related publications. A new US dyslipidemia guideline replaced the 2018 cholesterol guideline, a large outcomes trial of a PCSK9 antibody in patients with no prior heart attack or stroke was published, and the […]
